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General introduction 
 
 More than a century ago, a German psychiatrist and neuropathologist, Alois 
Alzheimer presented the case of a female patient and described a neurodegenerative disorder 
which bears his name. The main hallmarks of Alzheimer’s disease (AD) are cognitive decline, 
neuronal and synaptic loss mainly in neocortex and hippocampus, extracellular senile plaques 
and intracellular neurofibrillary tangles. 
 Alzheimer’s disease is an irreversible, progressive neurodegenerative disorder with an 
as yet unknown etiology, and despite intense research, there is no cure or effective therapy. It 
is the most common form of dementia among the elderly, affecting nearly 3% of the 
population over the age of 65, while 25-50% of people aged 85 suffer from AD and the great 
majority of them are females. Age is the dominant risk factor in AD, and by the improvement 
in life expectancy in welfare states, plausibly the number of patients will be doubled by 2050. 
There are about  7-8 million demented patients in Europe, 4–5 million in the USA with an 
increase to 14 and 16 millions, respectively, by 2050. Rates of increase in developed countries 
are forecasted by 100% between 2001 and 2040, but by more than 300% in India, China and 
their Asian neighbours. At the onset of the disease, patients show symptoms of mild cognitive 
impairment, but in the subsequent years, more severe memory loss occurs leading to 
confusion and lack of orientation. Eventually they often become institutionalized and 
bedridden, causing crescent expense to family members and society. 
 There are two forms of Alzheimer’s disease, sporadic and familial, and they share 
common histological and clinical symptoms. The extracellular deposites, mainly composed of 
the so-called β-amyloid peptide (Aβ), wich is a cleavage product of a membrane spanning 
amyloid precursor protein (APP), are thought to be primordial and the intracellular 
neurofibrillary tangles are secondary phenomena. The extracellular accumulation and 
aggregation of Aβ peptides seem to be liable for Alzheimer’s disease, but effective 
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Aims 
 
In the course of my Ph.D. work, we would have liked to reveal the answers for the following 
questions from an electrophysiological point of view.  
1. Have the different aggregational states of Aβ1-42 distinct effects on rat CA1 
postsynaptic ionotropic glutamate receptors? 
2. Amyloid β1-42 has an RHDS (Arg-His-Asp-Ser) within its sequence which resembles 
to RGD (Arg-Gly-Asp) motif of integrin ligands. Thus, are the effects of Aβ1-42 on 
AMPA and NMDA receptors due to the activation of integrin signaling?   
3. If yes, is it possible to interfere in the Aβ1-42-induced activation of integrin signaling? 
4. Is an N-protected pentapeptide able to penetrate the blood-brain barrier and to keep its 
protective effect after intraperitoneal administration? 
5. What effect has oligomer Aβ1-42 on synaptic plasticity? 
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Materials and Methods 
In vivo single-unit recordings and iontophoresis  
 
The head of chloral hydrate-anesthetized male Wistar rats weighing 280-330 g was 
mounted in a stereotaxic frame, the skull was opened above the hippocampus (antero-
posterior coordinates: -2.8 to -3.8 from bregma; lateral: 2 mm on either side from the 
midline), and the dura mater was carefully removed. The location of the electrode was 
verified by iontophoretic Pontamine Sky Blue ejection (-5 µA for 15 min) followed by 
conventional histology. The principles of laboratory animal care (NIH publication No. 85-23) 
and the protocol for animal care approved by the Hungarian Health Committee (1998) and the 
European Communities Council Directive of 24 November 1986 (86/609/EEC) were 
followed. 
Single-unit activity was recorded extracellularly by means of a low-impedance (< 1 
MΩ) 7 µm carbon fiber-containing microelectrode (Kation Scientific, Minneapolis, MN; 
Fig.3. (Szegedi, 2005, 181)). The action potentials were amplified (Szegedi, 2005, 181; 
Szegedi, 2005, 182), filtered, and then monitored with an oscilloscope. The filter bandpass 
frequencies were 300 to 8000 Hz. A window discriminator (WD-2, DAGAN, Minneapolis) 
was used for spike discrimination on the basis of spike amplitude and duration. The amplified 
signals were sampled and digitalized at 50 kHz. The number of action potentials per second 
was counted by the computer and peristimulus time histograms were calculated, displayed in 
line and digitally stored for off-line analysis (DataWave SciWorks Version 5.1). Iontophoretic 
drug delivery and experimental data collection were performed by a multifunction instrument 
control and data acquisition board PCI-1200 (National Instruments, Austin, Texas, USA) 
placed in a computer, programmed in LabVIEW 6, and by iontophoretic pumps (Minion-16 
and BAB-350, Kation Scientific).  
The drug barrels of the combined recording/iontophoresis electrode contained one of 
the following freshly made solutions: 100 mM NMDA Na salt (pH 8.0, Sigma), 10 mM 
AMPA hydrobromide (pH 8.0), the integrin ligand pentapeptide Gly-Arg-Gly-Asp-Ser 
(GRGDS) or the negative control pentaglycine (GGGGG, pH 6.4) either in the concentration 
of 5 mM or 50 mM; 0.1 mg/ml 4-Amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-
d]pyrimidine (InSolution™ PP2, Calbiochem), 0.1 mg/ml 4-Amino-7-phenylpyrazol[3,4-
d]pyrimidine (PP3, Calbiochem), 0.1 mg/ml anti-integrin antibodies (anti-β1 integrin, 
MAB1987Z; anti-α2 integrin, MAB1950Z; pH 9, Chemicon) and 50 µM Aβ1-42 sample (pH 
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6.4) either in fibrillar or oligomer form and to mark the position of the electrode, 4% 
Pontamine Sky Blue (PSB). Aβ1-42 containing samples were sonicated (Merck Eurolab 120 
W apparatus) for 15 min prior to use.  
NMDA and AMPA were ejected with negative iontophoretic currents ranging from 10 
to 100 nA. Retaining currents in the interval 2–16 nA of opposite direction were used. The 
current levels were selected during recording the control so that the spiking rate was to reach 
~30-80 spike/sec. In that way, the rate of amyloid or GRGDS induced excitation was not 
dependent of the initial firing rate. Following a stable control sequence,  Aβ1-42 was ejected 
at -380 nA for 60 sec, GRGDS or GGGGG was ejected for 3 min with +100 nA, while PP2 
and PP3 were ejected at +100 nA for 2 mins and the anti-integrin antibodies were ejected at -
100 nA for 2 mins. Cells were excited by alternating repetitive ejection of NMDA and AMPA 
and the interval between two excitation epochs was 120 s. In a set of experiments, in order to 
minimize the possible interaction between NMDA and AMPA receptor function, cells were 
excited by the ejection of either NMDA or AMPA alone. At this case, NMDA by itself was 
repetitively ejected every minute, whereas AMPA alone was repetitively applied in every 90 
sec.  
 Recording sites were marked by the iontophoretic ejection of PSB at a negative 
current of 5 µA for 10 min. At the end of each experiment, the animals were euthanized with 
an overdose of chloral hydrate. The brain was quickly removed and fixed in 4% 
paraformaldehyde. 50 µm thick brain sections were counterstained with Neutral Red, and the 
PSB localization was verified according to the stereotaxic atlas of Paxinos and Watson 
(1986).  
Ex vivo Electrophysiological recordings and stimulation protocols  
 
 Using standard procedures, 350 µm thick transverse acute hippocampal slices were 
prepared from the brain of 6 months old mice using a McIlwain tissue chopper (Campden 
Instruments, Loughborough, UK). Slices were incubated in carbogenated preparation solution 
at ambient temperature for 60 min, and then transferred to carbogenated standard ACSF (pH 
7.4) that contained the followings in mM: NaCl, 130; KCl, 3.5; CaCl2, 2; MgCl2, 2; NaH2PO4, 
0.96; NaHCO3, 24; D-glucose, 10. Individual slices were transferred to a 3D-MEA chip with 
60 tip-shaped electrodes (30 µm in diameter and 25 - 35 μm in height, spaced by 100 µm; 
purchased from Ayanda Biosystems, S.A., Lausanne, Switzerland; Fig. 4.). The surrounding 
solution was removed quickly and the slice was immobilized by a grid. The slice was 
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continuously perfused with carbogenated standard artificial cerebrospinal fluid (ACSF) (1.5 
ml/min at 34 °C) during the whole recording session. Data were recorded by a standard, 
commercially available MEA (multi-electrode array) setup (Multi Channel Systems MCS 
GmbH, Reutlingen, Germany).  
The Schaffer-collateral was stimulated by injecting a biphasic current waveform (± 100 µs) 
through one selected electrode at 0.033 Hz. The positioning of the stimulating electrodes and 
that of the regions in the slices, compared to each other, were constantly synchronized during 
the various investigations. The peak-to-peak amplitudes of field excitatory postsynaptic 
potentials (fEPSPs) at the distal and proximal part of stratum radiatum of CA1 were analyzed. 
After a 30 min incubation period, the threshold and the maximum of stimulation intensity for 
evoke responses was determined. For evoking responses, 30 % of the maximal stimulation 
intensity was used. When stable evoked fEPSPs were detected (for at least 20 min), the 
perfusion system was set to recycled and 1 μM oligomer amyloid was added into ACSF, than 
the wash-in period of amyloid was followed for an hour. Than a stimulus strength–evoked 
response curve (i.e. input–output, I–O curve) was recorded by gradually increasing stimulus 
intensity until the maximal stimulus strength was reached. The stimulus intensity was 
continuously increased from 0 to 100 μA with 10 μA steps. Stronger stimulation led to large 
Faradic effects on the electrodes causing artifacts. 3 data sets were recorded at each 
stimulation intensity. After I-O curve recordings, a paired-pulse facilitation (PPF) protocol 
was applied by administering two identical biphasic current waveform with 50 ms interval, 
repeated three times at 0.033 Hz. Following a stable 15-min control sequence after PPF 
protocol, LTP was induced, using a theta-burst stimulation (TBS) protocol applied at the 
maximum stimulation intensity. TBS comprised of 15 trains administered at 5 Hz, the 
individual trains contained 4 pulses separated by 10 ms. LTP was followed for 180 min. 
Finally, the depotentiation ability of the synapses was determined applying 3 Hz stimulation 
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Results and Discussion 
 
 As a result of the misfolding and aggregation, different Aβ species may exist and may 
have distinct effects on the pathomechanism of AD. There are contradictory results in the 
literature about the impaired function of NMDA and AMPA receptors in AD models. This 
may be because of the different aggregational states of Aβ1-42 used in those studies and the 
majority of them have not examined the actual Aβ form, thus the interpretation and 
comparison of data is rather difficult.  We have examined two well characterized forms of Aβ 
in our in vivo experiments and found that they similarly affect NMDA, but not AMPA 
receptors. Both the low n-aggregates and the highly aggregated forms of Aβ1-42 elevated the 
NMDA-evoked responses, while they have adverse effect on AMPA receptors, causing 
similar increase in NMDA-elicited responses in the case of oligomeric Aβ1-42, but a robust 
decrease after the application of fibrils. 
 The experiments of Tjernberg and Soto demonstrated that fragments of the Aβ 
sequence may be able to interfere with the process of Aβ aggregation. Based on the same 
concept, a protective pentapeptide, Phe-Arg-His-Asp-Ser (FRHDS), which is supposed to 
bind to integrin receptors was also reported. Peptides containing the Arg-Gly-Asp (RGD) 
recognition motif of the integrins enhance the fast AMPA receptor-dependent post-synaptic 
responses and modulate NMDA receptor function and subunit phosphorylation. 
 Based on these data, we have thought to explore the short time effects of integrin 
activation by an RGD peptide (GRGDS) on the function of NMDA and AMPA receptors. In 
this set of experiments, GRGDS was used both in low and in high concentration. The 
application of RGD containing peptide in low concentration enhanced NMDA-elicited 
responses, but attenuated AMPA-evoked neuronal firing, while high doses of GRGDS 
increased the responses of both NMDA and AMPA receptors. The control compound 
GGGGG did not affect the neuronal firing elicited neither by NMDA nor by AMPA. 
 The underlying mechanisms of integrin activation are relatively well described. The 
main candidate for mediating the signaling between integrin and NMDA/AMPA receptors is 
Src kinase, since Src inhibitors block the GRGDSP effects on NMDA and AMPA receptor 
transmission and the NMDA receptor-dependent ERK1/2 phosphorylation. However, the 
inhibitory action of low scale integrin activation has not been reported yet.  
 Thus we aimed to get some data that Aβ, containing Arg-His-Asp-Ser (RHDS) within 
its sequence,  which is somewhat similar to RGD and is required to activate integrins, acts 
troughout this pathway. We hipothetised that blocking either the integrin-Aβ binding or the 
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activation of Src results in the lack of increase in the NMDA-evoked neuronal firing after the 
application of fibrillar Aβ. To achieve this aim, we used antibodies against α2 (almost lacking 
in the hippocampus) and β1 integrin subunits, which are most prominent in the hippocampus 
and involved in the formation of synaptic plasticity, and we also used the Src tyrosine kinase 
inhibitor PP2 and as its control, the EGFR tyrosine kinase inhibitor PP3. When we ejected β1 
integrin antibody onto the recorded neuron just before the fAβ1-42 application, Aβ failed to 
increase the NMDA-elicited responses. Src tyrosine kinase is involved in the phosphorylation 
of NMDA subunits, and its blockade by the application of PP2 actually eliminated the 
NMDA-response enhancing effect of Aβ. In contrast, neither the α2 integrin antibody, nor the 
EGFR tyrosine kinase inhibitor was able to block the effect of Aβ on NMDA receptors. None 
of these compounds had any effect on basal NMDA-elicited neuronal firing alone. 
 A number of data indicate the participation of integrin activation and its downstream 
pathways in AD. Integrins are membrane spanning heterodimeric (α and β subunit) adhesion 
receptors integrating the extracellular matrix (ECM) with the cytoskeleton, hence 
corresponding to cell adhesion, motility, proliferation, apoptosis, induction of gene 
transcription and differentiation.  Extracellular matrix components e.g. collagen, fibronectin 
and laminin form fibrilloid structure just as the Aβ1-42. Integrins may not only bind these 
extracellular components, but also fAβ1-42, recognised as a fake member of ECM. Aβ1-42 
may mimic ECM molecules because of its misfolding and aggregation, and may trigger 
apoptosis as it was reported about the naturally globular albumin when it gained fibrillar form. 
This abnormal activation of integrins by fAβ1-42 may result in the reactivation of cell-cycle 
in CNS cells, overactivation of NMDA receptors via Src family kinases, leading to increased 
Ca
2+
 influx, eventually to cell death.  Either interfering with the direct amyloid-integrin 
binding, or the subtle modulation of downstream fyn kinase pathway may represent promising 
objectives for drug development for the treatment of AD.  
 Aβ1-42 derived pentapeptides are reported to be protective against the 
neuromodulatory and neurotoxic effects of fAβ1-42 both in vitro and in vivo. In a series of 
experiments, to further characterize the most effective one, LPYFDa was tested  whether it 
penetrates the blood brain barrier and keeps its protective effect. This N-protected 
pentapeptide was administered intraperitoneally and proved to be protective against the  
fAβ1-42, applied onto CA1 neurons by microiontophoresis. Recordings obtained  less than 80 
or more than 240 minutes after ip administration, showed no favourable effect of the peptide. 
However, between the time frame of 80-240 mins, LPYFDa eliminated the NMDA response 
enhancing effect of fAβ1-42. The control compound, GGGGG was unable to elicit such effect 
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in any of the observed time periods. Thus, it seems that LPYFDa and/or its metabolite may 
pass through the BBB within 80 minutes, and conserves its beneficial effect against fAβ1-42  
for almost three hours. After reaching an adequate concentration, it quickly intercepts 
iontophorised fAβ1-42, preventing the subsequent binding of the aggregated peptide to the 
cell surface. Further structure optimization of LPYFDa may enhance the efficiency of this 
lead pentapeptide and it may be exploited as a putative drug compound against AD.   
 LTP of synaptic transmission is regarded as a primary experimental model of memory 
formation and is often described as a Hebbian learning mechanism. There are controversial 
reports about Aβ1-42 effect on long-term memory. The Aβ1-42 that was used in our 
experiments have been extensively studied and characterized by various physico-chemical 
methods, such as transmission electronmicroscopy (TEM) and dynamic light scattering 
(DLS). Considering, that low-n oligomeric assemblies may have greater possibility to diffuse 
into the deeper cell layers of a slice, we have studied the electrophysiological effect of 
oligomer Aβ1-42 on acute hippocampal slices of adult mice using MEAs. It was found, that 
Aβ1-42 added into the perfused ACSF in 1 μM concentration, had no significant effect on 
basal elicited fEPSPs within the 1 hour wash-in period compared to controls. Because an 
increase of fEPSP amplitudes occured even in the case of control measurements, we 
performed I-O curve recordings after the Aβ1-42 wash-in. These recordings showed increased 
excitability and it is presumably the result of increased ionotropic glutamate receptor function, 
supporting our in vivo experiments.  
 It was found that in vivo application of oligomer Aβ1-42 enhances both the AMPA- 
and NMDA-elicited spiking rate. The AMPA and NMDA receptor hyperfunction may lead to 
the saturation of the net excitability, therefore impede further increase of the synaptic 
strength. AMPA receptors presumably contribute to stabilization of spines and their removal 
could lead to spine elimination. Overactivation of the functionally interconnected AMPA and 
NMDA receptors may result in their endocytosis respectively.  
 The increased NMDA (and GluR2 lacking, Ca
2+ 
permeable AMPA) currents and the 
VDCCs may easily alter the normal Ca
2+
 homeostasis. Thus, a PPF protocol was performed 
after the Aβ1-42 wash-in to evaluate the effect of the peptide on presynaptic function, which 
is higly dependent on proper Ca
2+ 
homeostasis. These results indicate impaired synaptic 
vesicle release and perturbation of Ca
2+
 regulation after wash-in compared to controls.  
 In order to investigate the effect of Aβ1-42 on LTP mechanisms, a strong LTP 
protocol was applied, which is eligible to induce all three forms of LTP. The results showed 
impairment mainly in the late, transcription-dependent phase and it was most prominent 2-3 h 
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after the induction of LTP. The depotentiation ability of synapses was also evaluated by 
applying LFS 3 hours after LTP induction. Slices treated with Aβ1-42 showed more robust 
depotentiation compared to untreated ones. The promotion of depotentiation was also reported 
about Aβ1-42 or its fragments by Shankar and Cheng, recently.    
 At first, we have found that Aβ1-42 impaired presynaptic function and increased 
excitability. Either the presynaptic vesicle release or the induction of LTP3 or LTD are related 
to proper Ca
2+
 influx. Our in vivo results indicated increased AMPA and NMDA currents 
after oligomer Aβ1-42 application. The proper function of NMDA receptors and L-type 
VDCCs is required to LTP3 induction. LTP3 is a transcription-dependent form of long term 
potentiation, and gene transcription is sensitive to temporal aspects of Ca
2+
 signals which is 
consistent with the requirement for repetitive HFS in the induction of LTP3. Results from the 
acute slice recordings suggest that oligomer Aβ1-42 impairs mainly the transcription-
dependent form of LTP, possibly via blocking the formation of e.g. new PSD proteins or 
proteins required for maintenance of extant spines.  
 These results represent that both low-n aggregates and fibrils of Aβ1-42 have rapid 
and significant effects on synaptic plasticity, and taken the data of Aβ1-42-induced 
suppression of LTP3 together with the promotion of depotentiation, these may lead to the 
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Summary 
 
First, we have evaluated the effects of different well characterized assemblies of Aβ1-42 on 
AMPA and NMDA receptors in vivo. The low-n aggregates augmented both the NMDA and 
the AMPA elicited firing of CA1 neurons while fibrillar Aβ1-42 affected adversely these 
receptors, elevating the currents of NMDA receptors, but waning or almost eliminating 
AMPA elicited firing. 
 
Second, we have tested whether Aβ1-42 exerts its effect via activating the integrin pathway. It 
seemed to be possible, that the RHDS within the sequence of Aβ1-42 may represent a ligand 
for integrin binding. Thus, we applied GRGDS onto CA1 neurons in low and high 
concentration to imitate the difference in the degree of possible binding surfaces of  oligomer 
and fibrillar Aβ1-42. The integrin ligand GRGDS showed similar effect in low concentration 
as fAβ1-42, and in high concentration as the oligomer aggregates.  
 
Third, we have further analyzed the integrin-activation by fAβ1-42.  We aimed to interfere in 
this pathway at integrin-fAβ1-42 binding and at Src kinase activation. Thus we used 
antibodies against integrins and inhibitors against kinases. Beta1 integrin antibody prevented 
the induction of this pathway while α2 not. The inhibitor of Src kinases, PP2 also blocked 
NMDA hyperfunction in contrast with EGFR kinase inhibitor PP3. 
 
Fourth, we have tested the BBB penetrating ability of LPYFDa by intraperitoneal 
administration. We found that this pentapeptide / or its metabolite is able to cross the BBB 
and still keeps its protective effect against the increase of fAβ1-42-induced NMDA elicited 
firing whithin a time frame of about 80-200 minutes after ip delivery.  
 
Fifth, we have examined  the impact of oligomer Aβ1-42 on synaptic plasticity using acute 
hippocampal mouse slices. Oligomer Aβ1-42 caused impairement of presynaptic function, 
increased the excitability of neurons, damaged the transcription-dependent phase of LTP, and 
enhanced the depotentiation after LTP induction.  
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